v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN REDEEMABLE PREFERRED STOCK AND SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Redeemable Preferred Stock
Common Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-controlling Interests
Beginning balance at Apr. 30, 2024   $ 177,110          
Beginning balance (in shares) at Apr. 30, 2024   177,110          
Beginning balance at Apr. 30, 2024 $ (209,377)   $ 19,909 $ 177,149   $ (406,435)  
Beginning balance (in shares) at Apr. 30, 2024     19,909,281        
Share-based compensation expense $ 24,271     24,271      
Issuance of redeemable preferred stock   $ 103,400          
Issuance of redeemable preferred stock (in shares) 0 103,400          
Issuance of stock to non-controlling interest $ 17,100           $ 17,100
Deemed dividend for payments to third party on behalf of shareholder (4,878)     (4,878)      
Conversion of Incentive Units to common shares on IPO (in shares)     651,577        
Conversion of Incentive Units to common shares on IPO     $ 652 (652)      
Capital contribution from West Affum LP 2,374     2,374      
Warrant modification upon IPO (1,171)     (1,171)      
Conversion of redeemable preferred stock to common shares on IPO (in shares)     15,444,716        
Conversion of redeemable preferred stock to common shares on IPO 280,510   $ 15,445 265,065      
Conversion of redeemable preferred stock to common shares on IPO ( in shares)   (280,510)          
Conversion of redeemable preferred stock to common shares on IPO   $ (280,510)          
Conversion of non-controlling interest to common shares on IPO (in shares)     1,645,893        
Conversion of non-controlling interest to common shares on IPO     $ 1,646 15,454     $ (17,100)
Issuance of common shares upon IPO or equity offering, net of underwriter discounts and issuance costs 210,391   $ 13,665 196,726      
Issuance of common shares upon IPO or equity offering, net of underwriter discounts and issuance costs (in shares)     13,664,704        
Issuance of restricted share awards     $ 32 (32)      
Issuance of restricted share awards (in shares)     32,485        
Net loss and comprehensive loss (113,814)         (113,814)  
Ending balance at Apr. 30, 2025 205,406   $ 51,349 674,306   (520,249)  
Ending balance (in shares) at Apr. 30, 2025     51,348,656        
Share-based compensation expense 33,644     33,644      
Issuance of common shares - exercise of warrant $ 4,054   $ 100 3,954      
Issuance of common shares - exercise of warrant     100,397        
Issuance of redeemable preferred stock (in shares) 0            
Deemed dividend for payments to third party on behalf of shareholder $ (495)     (495)      
Issuance of common shares upon IPO or equity offering, net of underwriter discounts and issuance costs 148,286   $ 6,900 141,386      
Issuance of common shares upon IPO or equity offering, net of underwriter discounts and issuance costs (in shares)     6,900,000        
Issuance of common shares - stock option exercises 593   $ 35 558      
Issuance of common shares - stock option exercises (in shares)     34,871        
Other comprehensive loss (218)       $ (218)    
Net loss and comprehensive loss (131,612)         (131,612)  
Ending balance at Apr. 30, 2026 $ 259,658   $ 58,384 $ 853,353 $ (218) $ (651,861)  
Ending balance (in shares) at Apr. 30, 2026     58,383,924